MDxHealth SA (MDXH)

USD 2.16

(-8.86%)

Total Debt Summary of MDxHealth SA

  • MDxHealth SA's latest annual total debt in 2023 was 41.26 Million USD , up 3.7% from previous year.
  • MDxHealth SA's latest quarterly total debt in 2024 Q2 was 56.66 Million USD , up 37.87% from previous quarter.
  • MDxHealth SA reported annual total debt of 39.79 Million USD in 2022, up 155.8% from previous year.
  • MDxHealth SA reported annual total debt of 15.55 Million USD in 2021, down -1.98% from previous year.
  • MDxHealth SA reported quarterly total debt of 56.66 Million USD for 2024 Q2, up 37.87% from previous quarter.
  • MDxHealth SA reported quarterly total debt of 40.73 Million USD for 2023 Q3, up 0.35% from previous quarter.

Annual Total Debt Chart of MDxHealth SA (2023 - 2004)

Historical Annual Total Debt of MDxHealth SA (2023 - 2004)

Year Total Debt Total Debt Growth
2023 41.26 Million USD 3.7%
2022 39.79 Million USD 155.8%
2021 15.55 Million USD -1.98%
2020 15.87 Million USD 44.26%
2019 11 Million USD 1991.63%
2018 526 Thousand USD -40.5%
2017 884 Thousand USD 64.31%
2016 538 Thousand USD -36.56%
2015 848 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD -100.0%
2012 1.43 Million USD 590.67%
2011 207.37 Thousand USD 3798.11%
2010 5319.86 USD 0.0%
2009 - USD -100.0%
2008 1392.10 USD -68.17%
2007 4374.01 USD -33.72%
2006 6599.00 USD -57.14%
2005 15.39 Thousand USD -48.37%
2004 29.82 Thousand USD 0.0%

Peer Total Debt Comparison of MDxHealth SA

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 53.08%
Prenetics Global Limited 2.36 Million USD -1641.589%
Star Equity Holdings, Inc. 3.6 Million USD -1043.392%
CareDx, Inc 34.22 Million USD -20.584%
Exact Sciences Corporation 2.55 Billion USD 98.385%
Exagen Inc. 23.72 Million USD -73.96%
Inotiv, Inc. 417.64 Million USD 90.12%
Guardant Health, Inc. 1.35 Billion USD 96.952%
Biodesix, Inc. 60.69 Million USD 32.008%
BioNexus Gene Lab Corp. 133.39 Thousand USD -30834.443%
Precipio, Inc. 1.11 Million USD -3597.581%
iSpecimen Inc. 196.24 Thousand USD -20927.394%
Natera, Inc. 441.99 Million USD 90.664%
Aspira Women's Health Inc. 2.26 Million USD -1721.05%
Standard BioTools Inc. 98.21 Million USD 57.983%
23andMe Holding Co. 76.51 Million USD 46.069%
Castle Biosciences, Inc. 15.31 Million USD -169.53%
Personalis, Inc. 48.96 Million USD 15.72%
Aclaris Therapeutics, Inc. 426 Thousand USD -9586.62%
Applied DNA Sciences, Inc. 1.23 Million USD -3233.845%
OpGen, Inc. 13.04 Million USD -216.359%
T2 Biosystems, Inc. 49.49 Million USD 16.633%
Myriad Genetics, Inc. 145 Million USD 71.541%
ICON Public Limited Company 3.93 Billion USD 98.952%
NeoGenomics, Inc. 611.67 Million USD 93.254%
Star Equity Holdings, Inc. 3.6 Million USD -1043.392%
IDEXX Laboratories, Inc. 947.88 Million USD 95.647%
RadNet, Inc. 1.49 Billion USD 97.233%
Psychemedics Corporation 2.29 Million USD -1695.692%
Illumina, Inc. 2.26 Billion USD 98.176%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 56.133%
DarioHealth Corp. 29.54 Million USD -39.687%
Fulgent Genetics, Inc. 14.9 Million USD -176.816%
Sera Prognostics, Inc. 1.85 Million USD -2120.936%
ENDRA Life Sciences Inc. 394.4 Thousand USD -10362.649%
OPKO Health, Inc. 326.56 Million USD 87.364%
Medpace Holdings, Inc. 142.12 Million USD 70.965%
Neogen Corporation 906.23 Million USD 95.447%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -4635.266%
Prenetics Global Limited 2.36 Million USD -1641.589%
Mainz Biomed B.V. 7.42 Million USD -456.074%
bioAffinity Technologies, Inc. 1.57 Million USD -2513.961%
Trinity Biotech plc 67.42 Million USD 38.8%
Neuronetics, Inc. 62.47 Million USD 33.949%
Sotera Health Company 2.32 Billion USD 98.227%
bioAffinity Technologies, Inc. 1.57 Million USD -2513.961%